Physician

Tidence Lane Prince, MD

According to 2025 Medicare claims, Tidence Prince, MD (NPI: 1215922356) practices allergy/immunology in the Knoxville, TN market, with the plurality of this provider's patient population coming from Blount, TN. This provider's primary affiliated billing organization is ALLERGY, ASTHMA, IMMUNOLOGY CENTER - TY PRINCE, PLLC (NPI: 1114752821; TIN: 994503916) and primary practice location at 37801-3904.

Prince's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 988 traditional Medicare patients, billed 86,760 HCPCS/CPT codes, and received $1,123,733 in Medicare payments. The top billing code was 70486 (Ct scan of face without contrast). Part D data shows 2,623 prescription claims across 639 beneficiaries totaling $2,492,647 in drug costs, led by Hizentra (Immun Glob G(Igg)/Pro/Iga 0-50). DME data shows 966 claims. Open Payments data shows 105 records totaling $25,590. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $300,735 to $1,123,733. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,068,508 to $2,492,647. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,032	25,660	$300,735
2016	1,032	32,568	$305,611
2017	1,015	45,516	$448,095
2018	1,142	55,029	$657,970
2019	1,161	99,669	$1,186,427
2020	1,090	140,312	$1,649,583
2021	1,050	138,906	$1,636,479
2022	1,037	134,875	$1,652,336
2023	1,044	130,899	$1,645,399
2024	988	86,760	$1,123,733

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	501	2,272	$2,068,508
2016	538	2,179	$1,693,818
2017	595	2,390	$925,530
2018	642	2,523	$2,591,025
2019	660	2,604	$3,164,897
2020	681	2,807	$3,346,126
2021	686	2,919	$3,408,023
2022	624	2,849	$3,134,038
2023	622	2,922	$2,859,505
2024	639	2,623	$2,492,647

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	171	1,633	$2,290,235
2016	205	1,595	$2,489,268
2017	193	1,700	$2,228,383
2018	165	1,572	$2,109,304
2019	149	1,690	$2,452,479
2020	161	1,682	$2,444,434
2021	140	1,561	$2,526,002
2022	122	1,389	$2,358,749
2023	115	1,374	$2,528,286
2024	102	966	$1,958,831

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
70486	Ct scan of face without contrast	85	87	$78
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	162	210	$59
95165	Professional service for preparation and provision of 1 or more antigens	419	13,061	$10
95117	Professional service for multiple injections of allergen	550	2,423	$7
95115	Professional service for single injection of allergen	93	347	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hizentra	Immun Glob G(Igg)/Pro/Iga 0-50	125	3,500	$671,777
Hyqvia	Igg/Hyaluronidase,recombinant	122	3,332	$630,150
Haegarda	C1 Esterase Inhibitor	12	336	$279,286
Xolair	Omalizumab	53	1,428	$175,490
Cinqair	Reslizumab	21	588	$100,701

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	16	150	$838,719
J1555	Injection, immune globulin (cuvitru), 100 mg	N	19	128	$690,366
J1575	Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin	N	N/R	47	$202,369
J1551	Injection, immune globulin (cutaquig), 100 mg	N	N/R	40	$195,087
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	27	245	$15,988

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	104	$25,590	Consortium of Independent Immunology Clinics, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$34,238	Consortium of Independent Immunology Clinics, LLC

Explore More Providers

FAQ

What Medicare data is available for Tidence Lane Prince, MD?

Tedicare shows public-source Medicare data for Tidence Lane Prince, MD (NPI 1215922356), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tidence Lane Prince, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Tidence Lane Prince, MD?

Tidence Lane Prince, MD is linked to ALLERGY, ASTHMA, IMMUNOLOGY CENTER - TY PRINCE, PLLC (billing NPI 1114752821) in the available physician profile data.

Does Tidence Lane Prince, MD have Open Payments data?

Tidence Lane Prince, MD has 105 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.